RB

Ram Babu Singh

Active Director Director DIN 08416454
DIN 08416454 First appointment Apr 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2019
Shareholding value •••• Premium profile

About Ram Babu Singh

Data last updated:

Ram Babu Singh is a Director at Blu Pharmaceutical Private Limited (since 2019). The company operates in Pharma. Blu Pharmaceutical Private Limited reported revenue of ₹4 Lakh (FY 2023).

DIN 08416454
Primary Designation Director
Industry Pharma
First Appointment 09 Apr 2019
Oldest Company Age 7 yrs
Largest company Blu Pharmaceutical Private Limited · ₹4 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Blu Pharmaceutical Private Limited U24299HR2019PTC079650
Director09 Apr 20192019₹4 Lakh (FY 2023)Active

Board colleagues of Ram Babu Singh

NameDINCompanyDesignation
Chirag Goyal08363592Blu Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Blu Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Ram Babu Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ram Babu Singh

Ram Babu Singh currently holds 1 directorship: Blu Pharmaceutical Private Limited (Director, since 09 Apr 2019, revenue ₹4 Lakh (FY 2023)).

Ram Babu Singh was first appointed on 09 Apr 2019 as Director at Blu Pharmaceutical Private Limited.

The current boards of Ram Babu Singh's companies include Chirag Goyal (Blu Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available